Design of deformable chitosan microspheres loaded with superparamagnetic iron oxide nanoparticles for embolotherapy detectable by magnetic resonance imaging
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Eun-Young | - |
dc.contributor.author | Kim, Hyeong-Min | - |
dc.contributor.author | Lee, Ga-Hyeon | - |
dc.contributor.author | Kwak, Byung-Kook | - |
dc.contributor.author | Jung, Ji-Sung | - |
dc.contributor.author | Kuh, Hyo-Jeong | - |
dc.contributor.author | Lee, Jaehwi | - |
dc.date.available | 2019-05-29T05:34:38Z | - |
dc.date.issued | 2012-11 | - |
dc.identifier.issn | 0144-8617 | - |
dc.identifier.issn | 1879-1344 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/20030 | - |
dc.description.abstract | The purpose of this study was to design chitosan microspheres (MS) loaded with superparamagnetic iron oxide nanoparticles (SPIO) suitable for anti-cancer embolotherapy detectable by MRI. Deformable chitosan MS loaded with varying SPIO concentrations (SPIO-chitosan MS) were prepared by ionotropic gelation and a porogenic technique using polyethylene glycol, followed by genipin crosslinking. Adding SPIO nanoparticles to chitosan MS did not significantly affect the chitosan MS morphology. An in vitro phantom study led to selecting SPIO-chitosan MS prepared with 1.0 mM SPIO for an in vivo MR traceability study. SPIO-chitosan MS could be identified following embolization in the renal artery by MRI at 18 weeks. Histological and pathological evidence also showed that SPIO-chitosan MS blocked and remained in the target vessels. Therefore, deformable SPIO-chitosan MS is MR-detectable embolic material with a possible application for anticancer embolotherapy. (C) 2012 Elsevier Ltd. All rights reserved. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.title | Design of deformable chitosan microspheres loaded with superparamagnetic iron oxide nanoparticles for embolotherapy detectable by magnetic resonance imaging | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.carbpol.2012.07.058 | - |
dc.identifier.bibliographicCitation | CARBOHYDRATE POLYMERS, v.90, no.4, pp 1725 - 1731 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.wosid | 000309331000045 | - |
dc.identifier.scopusid | 2-s2.0-84865677139 | - |
dc.citation.endPage | 1731 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 1725 | - |
dc.citation.title | CARBOHYDRATE POLYMERS | - |
dc.citation.volume | 90 | - |
dc.type.docType | Article | - |
dc.publisher.location | 영국 | - |
dc.subject.keywordAuthor | Deformable chitosan microsphere | - |
dc.subject.keywordAuthor | Superparamagnetic iron oxide | - |
dc.subject.keywordAuthor | Anti-cancer embolization | - |
dc.subject.keywordAuthor | Magnetic resonance imaging | - |
dc.subject.keywordAuthor | Traceability | - |
dc.subject.keywordPlus | TRISACRYL GELATIN MICROSPHERES | - |
dc.subject.keywordPlus | ARTERIAL EMBOLIZATION | - |
dc.subject.keywordPlus | IN-VIVO | - |
dc.subject.keywordPlus | CHITINS | - |
dc.subject.keywordPlus | CHEMOEMBOLIZATION | - |
dc.subject.keywordPlus | GENIPIN | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Polymer Science | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Applied | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalWebOfScienceCategory | Polymer Science | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
84, Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea (06974)02-820-6194
COPYRIGHT 2019 Chung-Ang University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.